Alzheimer’s Disease Leads to Chronic Pathological Changes and Inflammasome Signaling in an Animal Model of Traumatic Brain Injury
Cells · 2026
DOI: 10.3390/cells15181658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Erika D L R M Cabrera Ranaldi und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain Injuries, Traumatic, Inflammasomes, Signal Transduction. Die Arbeit nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institutes of Health / National Institute of Neurological Disorders and Stroke (NIH/NINDS), National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute on Aging (NIA).
Themen: Demenz
Abstract (Originalsprache)
Traumatic brain injury (TBI) is a significant public health concern, often resulting in long-term impairments. TBI is also a known risk factor for Alzheimer’s disease (AD), with both conditions sharing features such as inflammasome dysregulation. Inflammasome proteins are carried in extracellular vesicles (EVs) derived from blood plasma and serum. Our previous work showed that TBI in the context of AD acutely increases inflammasome activation and accelerates pathology. However, chronic effects of TBI in AD, particularly regarding sex differences, remain poorly characterized. Here, we used 3xTg-AD mice and wild-type (WT) controls, which underwent moderate controlled cortical impact (CCI) or sham surgery at 5 months of age. Mice were sacrificed at 3 months post-injury for biochemical and histopathological analysis. Cortical and hippocampal lysates were analyzed for inflammasome proteins and inflammatory cytokines via immunoblotting, while pathological markers were assessed using Ella Simple Plex technology and histopathology. In a separate cohort, 3xTg mice received moderate CCI and were sacrificed 7 days post-injury to evaluate sex differences. Cortical lysates were tested for pro-inflammatory cytokines and pathological markers via electrochemiluminescent immunoassay, and EVs were analyzed using mass spectrometry. AD-TBI mice showed increased expression of inflammasome proteins, pro-inflammatory cytokines, and glial fibrillary acidic protein (GFAP). TBI mice displayed elevated neurofilament light in the cortex, with both GFAP and neurofilament light co-localizing with inflammasome proteins in the perilesional cortex. Moreover, AD-TBI mice exhibited reduced cortical and hippocampal volumes compared to WT-TBI mice. In the sex differences cohort, EVs from male and female AD-TBI mice showed distinct patterns in upstream regulators and signaling pathways. Female-derived EVs showed greater activation of AD-related pathways. Sex-specific differences were also observed in cortical pro-inflammatory cytokine expression, although GFAP and amyloid-β levels were not significantly different between sexes. This study demonstrates that AD leads to changes in chronic inflammasome expression and neurodegenerative pathology, with marked sex-dependent differences in inflammatory and signaling responses in AD with TBI. These findings underscore the importance of considering both AD comorbidity and biological sex in the evaluation of TBI outcomes and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Department of Cellular Physiology and Molecular Biophysics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Bruce W. Carter Department of Veterans Affairs Medical Center, Miami, FL 33125, USA.
ORCID-Profile: Erika D L R M Cabrera Ranaldi, Helen M Bramlett, Robert W Keane, Juan Pablo de Rivero Vaccari
Förderung
- NINDS NIH HHS
- National Institutes of Health / National Institute of Neurological Disorders and Stroke (NIH/NINDS)
- National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute on Aging (NIA)
- NIH/NINDS
- NIH/NINDS/NIA
Zitieren
APA
Cabrera Ranaldi, E. D. L. R. M., Johnson, N. H., Sawaya, A. P., Herrera, J. R., Kerr, N. A., Bramlett, H. M., Keane, R. W., Dietrich, W. D., & de Rivero Vaccari, J. P. (2026). Alzheimer’s Disease Leads to Chronic Pathological Changes and Inflammasome Signaling in an Animal Model of Traumatic Brain Injury. Cells. https://doi.org/10.3390/cells15181658
Vancouver
Cabrera Ranaldi EDLRM, Johnson NH, Sawaya AP, Herrera JR, Kerr NA, Bramlett HM, et al. Alzheimer’s Disease Leads to Chronic Pathological Changes and Inflammasome Signaling in an Animal Model of Traumatic Brain Injury. Cells. 2026. doi:10.3390/cells15181658
BibTeX
@article{CabreraRanaldi2026,
author = {Cabrera Ranaldi, Erika D L R M and Johnson, Nathan H and Sawaya, Andrew P and Herrera, Jhianyn R and Kerr, Nadine Ahmed and Bramlett, Helen M and Keane, Robert W and Dietrich, W Dalton and de Rivero Vaccari, Juan Pablo},
title = {Alzheimer’s Disease Leads to Chronic Pathological Changes and Inflammasome Signaling in an Animal Model of Traumatic Brain Injury},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15181658}
}
EUVIMED